Steven Cohen's position in Crinetics Pharmaceuticals is currently worth $144 Million. That's 0.43% of their equity portfolio (52nd largest holding). The investor owns 4.89% of the outstanding Crinetics Pharmaceuticals stock. The first Crinetics Pharmaceuticals trade was made in Q3 2019. Since then Steven Cohen bought shares nine more times and sold shares on eight occasions. The stake costed the investor $70.4 Million, netting the investor a gain of 104% so far.